Pharmacyclics, E-Z-EM Inc. deal

E-Z-EM's London-based subsidiary received European marketing rights to

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE